NEW YORK (GenomeWeb News) – The US Food and Drug Administration has cleared BioFire Diagnostics' FilmArray Blood Culture Identification, or BCID, Panel, the company announced today.

The FDA clearance follows CE marking of the 27-target panel earlier this month. The Salt Lake City company filed its 510(k) submission to FDA for the test in April.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.